Phynova is a British life science company that develops and commercialises natural healthcare products derived from active compounds found in plants.
Founded in 2002, Phynova is an innovative life science company based in Oxford, UK with a subsidiary research company located in Beijing, China. Phynova develops and commercialises natural healthcare products derived from active compounds found in plants.
Phynova develops products for use in global healthcare and FMCG markets. It identifies active ingredients from plants with a rich history of use in traditional medicine, especially in China, and develops solutions for global health concerns.
Phynova Joint and Muscle Relief Tablets™ is the first ever traditional Chinese medicine approved as an OTC medicine by the Medicines and Healthcare products Regulatory Agency (MHRA; the UK’s regulatory body for medicines), under the 2004 EU Traditional Herbal Medicine Product (THMP) Directive. Phynova’s next OTC medicine, a cold and flu remedy, is being collaboratively developed with Xiangxue Pharmaceuticals, a Chinese pharmaceutical company, and an application has been submitted to the MHRA.
In addition to its growing OTC portfolio, Phynova is also pioneering novel plant-based products including its lead product Reducose®, a patented natural functional ingredient for blood-glucose control, PhynoRadiance®, a natural functional ingredient for skin pigmentation disorders, and Melokinex®, a pharmaceutical drug candidate for post-operative ileus.